Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cigna has seen material share price weakness in recent months, and trades in what I see as being deep-value territory. I see market concerns around the business as being overblown, and management targets robust free cash flow generation.

Cigna: Now The Perfect Stock To Build A Retirement Portfolio Around

Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for Cigna (CI)

Amgen

Activision Blizzard

Alibaba

BHP Billiton

Biogen

Cardinal Health

Clorox

D.R. Horton

FedEx

Corning

Global Payments

Intel

Micron Technology

Newmont Mining

NetEase

Nucor

QUALCOMM

Rio Tinto plc Sponsored

Seagate Technology Holdings PLC

Skyworks Solutions

Taiwan Semiconductor Manufacturing

V.F.

Vertex Pharmaceuticals

Buying The Dip: 27 High Quality Stocks Trading At A 20%+ Discount

SINGAPORE--(BUSINESS WIRE)-- #insurance--AM Best has placed under review with positive implications the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of Cigna Life Insurance New Zealand Limited (CLINZ) (New Zealand). These Credit Rating (rating) actions follow the announcement on 7 October 2021, that Cigna Corporation [NYSE:CI], CLINZ's ultimate parent, has entered into a definitive agreement to sell its life, accident and supplemental benefits business

AM Best Places Credit Ratings of Cigna Life Insurance New Zealand Limited Under Review With Positive Implications

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) and the Long- and Short-Term Issue Ratings of Cigna Corporation (Cigna) (Headquartered in Bloomfield, CT) [NYSE: CI] remain unchanged following Cigna's recent announcement that it has signed a definitive agreement to sell its life, accident and supplemental benefits business in seven countries to Chubb Limited. Additionally, the Financial Strength Ratings and Long-Term I

AM Best Comments on Credit Ratings of Cigna Corporation Following Asia-Pacific Business Sale Announcement

PayPal

Investing in these stocks could be a safe way to gain exposure to the growth of blockchain technology.

2 Growth Stocks Crypto Fans Would Love

Chubb

Cigna (CI) sells its businesses to Chubb to focus on core growth areas.

Cigna (CI) Divests Unit to Chubb to Streamline Business

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has commented that the Credit Ratings (ratings) of Chubb Limited (Chubb) [NYSE: CB] and its insurance subsidiaries remain unchanged following the company's announcement of a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna Corporation (NYSE: CI) in seven Asia-Pacific markets for $5.75 billion dollars in cash. (For a listing of Chubb's rating

AM Best Comments on Credit Ratings of Chubb Limited and Its Subsidiaries Following Announced Cigna Acquisitions in Asia-Pacific Markets

Chubb Limited (NYSE: CB) is buying the Asia Pacific and Turkey businesses of rival insurer Cigna Corp (NYSE: CI) for $5.75 billion in cash. The transaction is expected to be completed in 2022.

Cigna Offloads Life Insurance Business To Chubb In $5.75B Deal

Health insurer Cigna Corp said on Thursday it entered into an agreement with insurance firm Chubb Ltd to sell its life, accident, and supplemental benefits businesses in seven countries for $5.75 billion in cash.

Insurer Cigna to sell some businesses to Chubb for nearly $5.8 billion

ZURICH, Oct. 7, 2021 /PRNewswire/ -- Chubb Limited (NYSE: CB) today announced a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna (NYSE: CI) in seven Asia-Pacific markets for $5.75 billion dollars in cash. The operations to be acquired include Cigna's A&H and life business in Korea, Taiwan, New Zealand, Thailand, Hong Kong and Indonesia and its interest in a joint venture in Turkey.

Chubb to Acquire Cigna's $3 Billion Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets for $5.75 Billion

BLOOMFIELD, Conn., Oct. 7, 2021 /PRNewswire/ -- Cigna Corporation (NYSE:CI), a global health service company, today announced a definitive agreement with Chubb (NYSE: CB) to sell its life, accident and supplemental benefits businesses in seven countries for $5.75 billion dollars.

Cigna Reaches Agreement With Chubb To Divest Its Life, Accident And Supplemental Benefits Businesses In Seven Countries

Bank of China Ltd

China Construction Bank Corp

Glencore PLC

Honda

China Life Insurance Co. Ltd.

McKesson

Ping An Insurance Group Co of China Ltd

Sinopec Shanghai Petrochemical

China Petroleum & Chemical

AT&T

Toyota Motor

Verizon

Walmart

Exxon Mobil

August/September Fortune published the latest 500 "world's largest companies globally in 2020" (based on revenues) and 33 pay dividends. "A pandemic couldn't disrupt the top spot on the Fortune Global 500 for 2020. Mega-retailer, Walmart landed at number one on the list of the world's largest companies," Fortune states.

8 Of The Top 10 Global Fortune 500 Dividend Dogs Are Ideal In October

Cigna has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a strong 2.0% yield

Cigna A Top Socially Responsible Dividend Stock With 2.0% Yield

Cigna (CI) unveils enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties and states to offer enhanced health outcomes.

Cigna's (CI) 2022 Expansion Plans to Boost MA Customer Base

Cigna (CI) is benefiting on the back of robust segmental performances and well-diversified healthcare suite. A strong partner network throughout U.S. is an added advantage.

Here's Why You Should Retain Cigna (CI) Stock for Now

Humana

UnitedHealth Group

Several health insurers including Cigna Corp. CI, -1.85% , Humana Inc. HUM, -1.57% , and UnitedHealth Group Inc. UNH, -2.42% announced Friday that they are expanding their geographic presence in the Medicare Advantage market. The annual election period for Medicare is between Oct. 15 and Dec. 7 for 2022.

Cigna, Humana, UnitedHealth to expand into new Medicare Advantage markets in 2022

NASHVILLE, Tenn., Oct. 1, 2021 /PRNewswire/ -- Cigna announced its third consecutive year of record geographic expansion in Medicare Advantage (MA) while maintaining affordability and continuing to offer benefits that meet the unique needs of Americans age 65+ and others who qualify for the program.

Cigna Expands Medicare Advantage Plans for Third Consecutive Year, Making it Easier for Customers to Access Affordable, Predictable, Simple Health Care Options

Albertsons Companies

eBay

Dividend growth tends to slow over time. Getting in early can lead to outsized dividend growth.

Boost Your Income With These Future Dividend Growth All-Stars

Health insurer Cigna Corp on Thursday named Eric Palmer as president and chief executive officer of Evernorth, its health services unit that mainly houses its pharmacy benefit management business.

Cigna names new CEO of pharmacy benefit management business

BLOOMFIELD, Conn., Sept. 23, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced several new leadership roles and positions to drive accelerated growth across its diverse business portfolio.

Cigna Announces Leadership Changes to Continue Accelerating Business Growth

It is an excellent business with a track record of consistent and stable growth. Free cash flow, operating earnings and stock chart performance are suggesting that business could be undervalued.

Cigna: Getting Close To Being Very Attractive

BLOOMFIELD, Conn., Sept. 17, 2021 /PRNewswire/ -- With children and families facing unprecedented challenges due to the stress of the pandemic, Cigna Foundation is teaming up with nonprofits across the country to ensure underserved students and families have access to healthy food and mental health support in schools.

Cigna Foundation Expands Commitment to Help Thousands of Students, Educators, and Families Access Healthy Food, Mental Health Support

AmerisourceBergen

Lockheed Martin

With most stock indices near all-time highs and lofty valuations on most mega-cap stocks, it can be difficult to find good long-term values right now in the overall stock market. At the individual stock level, however, there are a few solid values even within the components of the S&P 500 index that aren't cyclical in nature.

3 Stock Ideas For An Expensive Market

Shares of Cigna Corp (NYSE: CI) are down more than 20% from their year-to-date high in May, and the Bank of America says the prospect of a swift recovery is not very bright either. In a note on Friday, BofA's Kevin Fischbeck double downgraded Cigna to “underperform” with a price target of $225 that represents […] The post Bank of America double downgrades Cigna Corp to ‘underperform' appeared first on Invezz.

News for Cigna Stock (CI)